Does the current crisis have the collateral effect of making antibiotic research and development much more in the forefront of the minds of governments across the globe even though this current pandemic is driven by a virus? If so, it sure seems like B has all of a sudden become a much more valuable drug, especially if the ongoing testing point to B as treatment for COVID19.